Risedronate and alanine aminotransferase increased Patient Reports February 12, 2012

Risedronate Side Effects Report #5890688-0
Risedronate side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Female patient, 73 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, decreased appetite, gastritis erosive, jaundice , liver disorder. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ALFAROL, ASPARA, ZOLPIDEM TARTRATE, ETODOLAC, METHYCOBAL, SOLON, CRESTOR, EPADEL. Patient recovered.

Risedronate Side Effects Report #5954623-9
Risedronate side effect was reported by a Physician from JAPAN on Oct 27, 2008. Female patient, 72 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, gamma-glutamyltransferase increased, hepatic function abnormal, hypersensitivity. Risedronate dosage: 2.5 MG ONCE DAILY, ORAL. During the same period patient was treated with VOLTAREN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5140802-X
Risedronate side effect was reported by a Physician from JAPAN on Oct 19, 2006. Female patient, 71 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase increased, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with PENFILL R. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5023449-5
Risedronate side effect was reported by a Physician from JAPAN on May 23, 2006. Female patient, 69 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, blood creatinine increased, blood pressure decreased, blood urea increased, cardiomegaly, chest discomfort, chest pain . Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, DEPAS, DICLOFENAC. Patient was hospitalized. Patient recovered.


Risedronate Side Effects Report #5043236-1
Risedronate side effect was reported by a Physician from JAPAN on June 12, 2006. Female patient, 69 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, aortic calcification, ascites, aspartate aminotransferase increased, base excess, bladder disorder, blood calcium decreased, blood cholesterol increased. Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, DEPAS, DICLOFENAC. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #4750396-6
Risedronate side effect was reported by a Health Professional from JAPAN on Aug 05, 2005. Female patient, 66 years of age, was diagnosed with osteoporosis , pyrexia, cough and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, body temperature increased, c-reactive protein increased, chest x-ray abnormal, cough, cryptogenic organizing pneumonia. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with MEFENAMIC ACID, ASTHMOYLSIN, NIPOLAZIN, PRAVASTATIN, NEUROTROPIN, MENATETRENONE, SAIREI, CINAL. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #4621086-5
Risedronate side effect was reported by a Physician from on Mar 14, 2005. Female patient, 64 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with VITAMIN D3, URSODIOL, MEVALOTIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #4654066-4
Risedronate side effect was reported by a Physician from on Apr 19, 2005. Female patient, 62 years of age, was diagnosed with osteoporosis , nasopharyngitis and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, aphasia , aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood cholinesterase increased, blood lactate dehydrogenase increased, depressed level of consciousness. Risedronate dosage: 2.5 MG ONCE, ORAL. During the same period patient was treated with LOXONIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5485937-7
Risedronate side effect was reported by a Physician from JAPAN on Sept 27, 2007. Male patient, 60 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, leukopenia, platelet count decreased, pyrexia, red blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with PREDNISONE, LORFENAMIN, MUCOSTA, SULFAMETHOXAZOLE, VITAMEDIN. Patient was hospitalized. Patient recovered.


Risedronate Side Effects Report #5003416-8
Risedronate side effect was reported by a Physician from JAPAN on Apr 26, 2006. Female patient, 54 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, ovarian cancer, uterine polyp, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. Patient recovered.

Risedronate Side Effects Report #5020725-7
Risedronate side effect was reported by a Physician from JAPAN on May 12, 2006. Female patient, 54 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, metrorrhagia, ovarian cancer, uterine polyp, white blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. Patient recovered.